InvestorsHub Logo
Followers 78
Posts 10240
Boards Moderated 9
Alias Born 06/06/2017

Re: None

Tuesday, 04/02/2019 10:57:37 PM

Tuesday, April 02, 2019 10:57:37 PM

Post# of 279
ADMA Biologics (NASDAQ: ADMA)
5.02 +0.95 (23.37%)

Analyst Ratings
Find Analyst Ratings for:

Date
Research Firm
Action
Current
PT
4/02/19
Oppenheimer
Maintains
Outperform
16.0
2/07/19
H.C. Wainwright
Assumes
Buy
10.0
10/30/18
H.C. Wainwright
Initiates Coverage On
Buy
17.0
10/12/18
Raymond James
Maintains
Outperform
10.0
7/30/18
Chardan Capital
Initiates Coverage On
Buy
10.0
7/27/18
Maxim Group
Maintains
Buy
12.0
7/26/18
Maxim Group
Maintains
Buy
12.0
7/13/18
Oppenheimer
Initiates Coverage On
Outperform
13.0
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADMA News